Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.72003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 22.06.2026. Verfasst von Nicolas Wentzensen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Fallopian Tube Neoplasms, Ovarian Neoplasms, Ovariectomy, Peritoneal Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural Research Program of the National Cancer Institute.
Abstract (Originalsprache)
Background
Most ovarian cancers are detected at advanced stages, with poor outcomes. Ovarian cancer is heterogeneous; the most common subtype, serous ovarian carcinoma, may originate outside of the ovaries. To inform etiologic heterogeneity, prevention, and treatment of ovarian cancer, we conducted the first evaluation of oophorectomy‐corrected incidence and mortality trends of ovarian, fallopian tube, and peritoneal cancers.
Methods
Ovarian cancer incidence, survival, and incidence‐based mortality overall and by subtype were analyzed using the U.S. Surveillance, Epidemiology, and End Results (SEER)‐22 and SEER17 databases including cases from 2000 to 2019, with oophorectomy correction based on data from the National Health and Nutrition Examination Survey (NHANES). Rates were age adjusted per 100,000 person‐years; annual percent changes in rates were calculated.
Results
Age‐adjusted prevalence of oophorectomy changed minimally between 2000 and 2019 and was highest among Non‐Hispanic White women. Oophorectomy‐correction increased ovarian cancer incidence rates by 23% on average. Ovarian cancer incidence decreased by 2% between 2000 and 2019, with a stronger reduction observed in recent years. Fallopian tube cancer incidence increased by 7% from 2000 to 2019. Relative 5‐year survival was lowest among Non‐Hispanic Black women even after accounting for histotype and stage. Ovarian cancer mortality decreased by 1.8% between 2000 and 2019. Serous carcinomas contributed to 68% of ovarian cancer cases, but 83% of all ovarian cancer deaths.
Conclusions
The reasons for decreasing ovarian cancer incidence are not understood. There is evidence for some reclassification of primary ovarian to primary fallopian tube cancers. Low survival rates in Non‐Hispanic Black women point to disparities along the continuum of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA.
- Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Nicolas Wentzensen, Megan A Clarke
Förderung
- Intramural Research Program of the National Cancer Institute
Zitieren
APA
Wentzensen, N., Cohen, C., Harvey, S., Erickson, B. K., & Clarke, M. A. (2026). Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.72003
Vancouver
Wentzensen N, Cohen C, Harvey S, Erickson BK, Clarke MA. Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.72003
BibTeX
@article{Wentzensen2026,
author = {Wentzensen, Nicolas and Cohen, Camryn and Harvey, Summer and Erickson, Britt K and Clarke, Megan A},
title = {Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.72003}
}
EUVIMED